Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04554693 · ClinicalTrials.gov registry record · Phase 4
The Use of Low Dose Metronidazole to Decrease Postoperative Pain After Endometriosis Surgery
A Phase 4 study of Endometriosis and Endometriosis-related Pain, sponsored by University of Louisville.
- Active
- Registry status
- Phase 4
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT04554693: Active Phase 4 study of Endometriosis and Endometriosis-related Pain, sponsored by University of Louisville.
NCT04554693 is a Phase 4 study of Endometriosis and Endometriosis-related Pain that is active but no longer recruiting, run by University of Louisville. The registered enrollment target is 90 participants, below the 262-participant average among 48 other Endometriosis trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04554693, a Phase 4 study of Endometriosis and Endometriosis-related Pain, is active but no longer recruiting, sponsored by University of Louisville.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine a difference in participant reported pain after endometriosis surgery in participants given oral metronidazole versus placebo.
Primary Outcome
The outcome of binary, subject pain persistence, assessed as yes or no, will be compared between groups using the Fisher exact test.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Metronidazole Oral
Study Locations (1)
Kentucky
- University of Louisville Hospital - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2020-10-19 |
| Est. Completion | 2027-09 |
| Phase | Phase 4 |
What the registry record for NCT04554693 still lists
NCT04554693 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 262-participant average among 48 other Endometriosis trials with a reported enrollment target (66% lower).
The record links to 2 conditions, with Endometriosis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04554693 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT04554693 about?
NCT04554693 is a clinical study titled "The Use of Low Dose Metronidazole to Decrease Postoperative Pain After Endometriosis Surgery". The purpose of this study is to determine a difference in participant reported pain after endometriosis surgery in participants given oral metronidazole versus placebo.
What is the current status of trial NCT04554693?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 90 participants. The study started on 2020-10-19. Estimated completion is 2027-09.
What conditions does trial NCT04554693 study?
This clinical trial studies the following conditions: Endometriosis, Endometriosis-related Pain.
What interventions are being tested in trial NCT04554693?
The interventions under investigation include: Placebo (DRUG), Metronidazole Oral (DRUG).
Who is sponsoring clinical trial NCT04554693?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04554693 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometriosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04554693's enrollment target sits among peer trials
90 27th of 48 higher than 22 of 48 other Endometriosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Endometriosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Thromboxane Function in Women With Endometriosis
RECRUITING · Phase 4
-
Superior Hypogastric Nerve Plexus Block With Bupivacaine After Robotic Resection of Endometriosis
RECRUITING · Phase 4
-
Endometriosis and Microvascular Dysfunction; Simvastatin and Duavee
RECRUITING · Phase 4
-
Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF
COMPLETED · Phase 4
-
Supplementation in Adolescent Girls With Endometriosis
COMPLETED · Phase 4
-
Interdisciplinary Group Care for the Treatment of Endometriosis-associated Pain
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI